Substrate
science

CDC Temporarily Restricts Entry for Some Travelers from Three African Countries

The CDC has issued a temporary order barring certain non-U.S. citizens who were recently in the DRC, Uganda, or South Sudan from entering the United States. U.S. citizens, nationals, and lawful permanent residents may still enter but will face enhanced screening.

CD
1 source·May 21, 9:16 PM(7 days ago)·1m read
CDC Temporarily Restricts Entry for Some Travelers from Three African Countriesnews.google.com
Audio version
Tap play to generate a narrated version.

The order took effect May 18, 2026, and is set to last 30 days while the agency completes a public health risk assessment. U.S. citizens, nationals, and lawful permanent residents may still enter the country but will undergo enhanced screening. Travelers permitted to enter will have their flights re-routed to Washington-Dulles International Airport beginning May 20, 2026, at 11:59 PM.

Screening includes a questionnaire about travel history and symptoms, temperature checks with non-contact thermometers, and observation by CDC staff. Travelers without symptoms will receive information about monitoring their health for 21 days after leaving the affected countries.

Travelers who develop symptoms during screening will receive additional evaluation by a CDC public health officer and may be transferred to a hospital for further assessment and isolation.

The CDC will use automated text messages to remind arriving travelers to monitor for symptoms and to contact public health authorities if needed. Contact information will also be shared with state and local health departments for follow-up. There are currently no suspected, probable, or confirmed Ebola cases in the United States, and the risk to the American public remains low.

The measures are part of a layered public health strategy that includes exit screening overseas and airline illness reporting.

Key Facts

Entry restriction
Applies to certain non-U.S. citizens in DRC, Uganda, or South Sudan within past 21 days
Duration
Temporary order set for 30 days pending risk assessment
Screening location
Washington-Dulles International Airport for affected travelers
Monitoring period
21 days after leaving affected countries

Story Timeline

3 events
  1. May 18, 2026

    CDC order restricting certain travelers from DRC, Uganda, and South Sudan took effect.

    1 source@CDCgov
  2. May 20, 2026

    Affected travelers began re-routing to Washington-Dulles International Airport.

    1 source@CDCgov
  3. May 21, 2026

    CDC published traveler guidance on entry restrictions and screening procedures.

    1 source@CDCgov

Potential Impact

  1. 01

    Some travelers will have flights re-routed to Washington-Dulles International Airport.

  2. 02

    State and local health departments will receive contact information for arriving travelers.

  3. 03

    Travelers may face additional evaluation if symptoms appear during screening.

Transparency Panel

Sources cross-referenced1
Confidence score70%
Synthesized bySubstrate AI
Word count212 words
PublishedMay 21, 2026, 9:16 PM
Bias signals removed1 across 1 outlet
Signal Breakdown
Loaded 1

Related Stories

WHO Director Visits Congo as Ebola Outbreak SpreadsNpr
science3 hrs ago

WHO Director Visits Congo as Ebola Outbreak Spreads

The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.

Npr
France 24
2 sources
Benzinga Publishes Article on Biotech Stocks During Pandemic Recoveryfinance.yahoo.com
science5 hrs agoDeveloping

Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery

Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…

Benzinga
1 source
FDA Panel Recommends XFG Variant for Fall Covid Shotsmedpagetoday.com
science1 hr agoDeveloping

FDA Panel Recommends XFG Variant for Fall Covid Shots

Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.

Stat
1 source